diazooxonorleucine has been researched along with Soft Tissue Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amato, DJ; Borden, EC; Chang, AY; Comis, RL; Davis, TE; Dowd, ME; Earhart, RH; Shiraki, M; Smith, TJ | 1 |
1 trial(s) available for diazooxonorleucine and Soft Tissue Neoplasms
Article | Year |
---|---|
Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas.
Topics: Aclarubicin; Azo Compounds; Bone Neoplasms; Diazooxonorleucine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Mesothelioma; Middle Aged; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms | 1990 |